These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 25095259)

  • 1. Modeling CD40-based molecular communications in blood vessels.
    Felicetti L; Femminella M; Reali G; Gresele P; Malvestiti M; Daigle JN
    IEEE Trans Nanobioscience; 2014 Sep; 13(3):230-43. PubMed ID: 25095259
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interaction with damaged vessel wall in vivo in humans induces platelets to express CD40L resulting in endothelial activation with no effect of aspirin intake.
    Giannini S; Falcinelli E; Bury L; Guglielmini G; Rossi R; Momi S; Gresele P
    Am J Physiol Heart Circ Physiol; 2011 Jun; 300(6):H2072-9. PubMed ID: 21378140
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neutrophil CD40 enhances platelet-mediated inflammation.
    Vanichakarn P; Blair P; Wu C; Freedman JE; Chakrabarti S
    Thromb Res; 2008; 122(3):346-58. PubMed ID: 18289643
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The multi-functionality of CD40L and its receptor CD40 in atherosclerosis.
    Lievens D; Eijgelaar WJ; Biessen EA; Daemen MJ; Lutgens E
    Thromb Haemost; 2009 Aug; 102(2):206-14. PubMed ID: 19652870
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The CD40-CD40L system in cardiovascular disease.
    Pamukcu B; Lip GY; Snezhitskiy V; Shantsila E
    Ann Med; 2011 Aug; 43(5):331-40. PubMed ID: 21244217
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CD40 is constitutively expressed on platelets and provides a novel mechanism for platelet activation.
    Inwald DP; McDowall A; Peters MJ; Callard RE; Klein NJ
    Circ Res; 2003 May; 92(9):1041-8. PubMed ID: 12676820
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Platelets and endothelial cells.
    Siegel-Axel DI; Gawaz M
    Semin Thromb Hemost; 2007 Mar; 33(2):128-35. PubMed ID: 17340460
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CD40 ligand on activated platelets triggers an inflammatory reaction of endothelial cells.
    Henn V; Slupsky JR; Gräfe M; Anagnostopoulos I; Förster R; Müller-Berghaus G; Kroczek RA
    Nature; 1998 Feb; 391(6667):591-4. PubMed ID: 9468137
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CD40-CD40 ligand mediates the recruitment of leukocytes and platelets in the inflamed murine colon.
    Vowinkel T; Anthoni C; Wood KC; Stokes KY; Russell J; Gray L; Bharwani S; Senninger N; Alexander JS; Krieglstein CF; Grisham MB; Granger DN
    Gastroenterology; 2007 Mar; 132(3):955-65. PubMed ID: 17324402
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CD40 ligand is selectively expressed on CD4+ T cells and platelets: implications for CD40-CD40L signalling in atherosclerosis.
    Büchner K; Henn V; Gräfe M; de Boer OJ; Becker AE; Kroczek RA
    J Pathol; 2003 Oct; 201(2):288-95. PubMed ID: 14517846
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Platelet-vessel wall interactions in the microcirculation.
    Tailor A; Cooper D; Granger DN
    Microcirculation; 2005; 12(3):275-85. PubMed ID: 15814436
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Activated platelets induce tissue factor expression on human umbilical vein endothelial cells by ligation of CD40.
    Slupsky JR; Kalbas M; Willuweit A; Henn V; Kroczek RA; Müller-Berghaus G
    Thromb Haemost; 1998 Dec; 80(6):1008-14. PubMed ID: 9869175
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CD40/CD40L interaction induces E-selectin dependent leukocyte adhesion to human endothelial cells and inhibits endothelial cell migration.
    Urban D; Thanabalasingam U; Stibenz D; Kaufmann J; Meyborg H; Fleck E; Gräfe M; Stawowy P
    Biochem Biophys Res Commun; 2011 Jan; 404(1):448-52. PubMed ID: 21138731
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Soluble CD40 ligand impairs the anti-platelet function of peripheral blood angiogenic outgrowth cells via increased production of reactive oxygen species.
    Bou Khzam L; Hachem A; Zaid Y; Boulahya R; Mourad W; Merhi Y
    Thromb Haemost; 2013 May; 109(5):940-7. PubMed ID: 23426185
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immune-mediated and lipid-mediated platelet function in atherosclerosis.
    Ahmadsei M; Lievens D; Weber C; von Hundelshausen P; Gerdes N
    Curr Opin Lipidol; 2015 Oct; 26(5):438-48. PubMed ID: 26270811
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cell-cell interaction and tissue factor expression.
    Lorenzet R; Napoleone E; Celi A; Pellegrini G; Di Santo A
    Blood Coagul Fibrinolysis; 1998 Mar; 9 Suppl 1():S49-59. PubMed ID: 9819029
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biologically active CD40 ligand is elevated in sickle cell anemia: potential role for platelet-mediated inflammation.
    Lee SP; Ataga KI; Orringer EP; Phillips DR; Parise LV
    Arterioscler Thromb Vasc Biol; 2006 Jul; 26(7):1626-31. PubMed ID: 16601237
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Platelets and chemokines in atherosclerosis: partners in crime.
    Weber C
    Circ Res; 2005 Apr; 96(6):612-6. PubMed ID: 15802619
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of alimentary lipemia and inflammation on platelet CD40-ligand.
    Kälsch T; Elmas E; Nguyen XD; Kralev S; Leweling H; Klüter H; Dempfle CE; Borggrefe M
    Thromb Res; 2007; 120(5):703-8. PubMed ID: 17289125
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Homocysteine modulates the CD40/CD40L system.
    Prontera C; Martelli N; Evangelista V; D'Urbano E; Manarini S; Recchiuti A; Dragani A; Passeri C; Davì G; Romano M
    J Am Coll Cardiol; 2007 Jun; 49(22):2182-90. PubMed ID: 17543638
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.